Stock Screener App

Frei -

Installieren

9.69

2.76% 0.26

Lyell Immunopharma Inc (LYEL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Lyell Immunopharma Inc-Aktie (LYEL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	76.92% 0.003	0.013	0.025	0.027	0.065
Operating Expenses	6.62% 55.58	59.52	59.06	65.93	62.62
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	6.62% 55.58	59.52	59.06	65.93	62.62
Operating Income/Loss	6.61% -55.58	-59.51	-59.04	-65.91	-62.56
Nonoperating Income/Loss	177.41% -5.092	6.578	8.186	2.015	-4.403
Income/Loss From Continuing Operations Before Tax	76.92% 0.003	0.013	0.025	0.027	0.065
Income/Loss From Continuing Operations After Tax	14.62% -60.67	-52.93	-50.85	-63.89	-66.96
Net Income/Loss	14.62% -60.67	-52.93	-50.85	-63.89	-66.96
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	41,856% 254.25	0.606	251.32	250.20	249.59
Diluted Average Shares	41,856% 254.25	0.606	251.32	250.20	249.59
Basic Earnings Per Share	20.00% -0.24	-0.20	-0.20	-0.26	-0.27
Diluted Earnings Per Share	20.00% -0.24	-0.20	-0.20	-0.26	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$20.30

0.68%

RPRX

$36.37

0.50%

SMMT

$24.55

8.53%

INSM

$97.80

0.45%

BNTX

$110.00

1.61%

ONC

$245.49

0.48%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters